Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Prevention of rotavirus disease: guidelines for use of rotavirus vaccine äPediatrics 2007[Jan]; 119 (1): 171-82On February 3, 2006, a bovine-based pentavalent rotavirus vaccine (RotaTeq, Merck & Co Inc, Whitehouse Station, NJ) was licensed by the US Food and Drug Administration for use in infants in the United States. The American Academy of Pediatrics recommends routine immunization of infants with 3 doses of pentavalent rotavirus vaccine administered orally at 2, 4, and 6 months of age. The first dose should be administered between 6 and 12 weeks of age; immunization should not be initiated for infants older than 12 weeks of age. Subsequent doses should be administered at 4- to 10-week intervals, and all 3 doses of vaccine should be administered by 32 weeks of age. Pentavalent rotavirus vaccine can be coadministered with other childhood vaccines. Pentavalent rotavirus vaccine is contraindicated for infants with a serious allergic reaction to any vaccine component or to a previous dose of vaccine.|*Immunization Schedule[MESH]|Administration, Oral[MESH]|Feces/virology[MESH]|Gastroenteritis/*prevention & control/virology[MESH]|Humans[MESH]|Immunocompromised Host[MESH]|Infant[MESH]|Infant, Newborn[MESH]|Infant, Premature[MESH]|Risk Factors[MESH]|Rotavirus Infections/epidemiology/*prevention & control[MESH]|Rotavirus Vaccines/*administration & dosage/adverse effects/immunology[MESH]|Rotavirus/isolation & purification[MESH]|United States/epidemiology[MESH]|Vaccines, Attenuated/*administration & dosage/adverse effects/immunology[MESH] |
